Industry News Roundup
This article was originally published in The Tan Sheet
Health One ceases operations under consent decree; U.K. scraps nonprescription diclofenac oral products; nano NSAIDS platform closer to launch; NDI suspected in GMP inspection; Import lavender nasal spray detained; and more news in brief.
You may also be interested in...
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Genfit will delay unblinding of data from its nearly complete Phase III study of elafibranor to get insight from the FDA on statistical methods in order to optimize its NDA.
Revolution has just one drug in the clinic, but its focus on KRAS excited IPO investors. Also, Deciphera’s $175m offering leads recent follow-ons and Spruce raises $88m in venture capital.